Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Fussenegger
Markus Fussenegger, Dornbirn AT
| Patent application number | Description | Published |
|---|---|---|
| 20110107248 | Computer-aided System for Managing and/or Controlling a Building Management System - In a computer-assisted system for managing and/or controlling a building management system, which system has a plurality of actuators, in particular lamps, sensors and/or command transmitters, which are located in different rooms, a database is provided, in which database information relating to the actuators, sensors and/or command transmitters of the building management system and also data about an axial cell structure of the building are stored. The system is designed to provide a graphical user interface on a display, on which graphical user interface the building and the arrangement of the actuators, sensors and/or command transmitters located in said building are graphically displayed. | 05-05-2011 |
Martin Fussenegger, Magenwil CH
| Patent application number | Description | Published |
|---|---|---|
| 20110053880 | COMPOSITION FOR TREATMENT OF TUBERCULOSIS - The invention relates to a pharmaceutical composition comprising a compound preventing EthR from binding to the ethA promoter, for example a compound of formula 1 wherein R | 03-03-2011 |
| 20110151006 | STIMULI-RESPONSIVE HYDROGEL - The present invention relates to a hydrogel comprising a polymer, a first polypeptide and a polypeptide binding partner, wherein the polypeptide binding partner is a second polypeptide, a nucleic acid or a small molecule, and wherein the interaction between the first polypeptide and the polypeptide binding partner stabilizes the hydrogel and is modulated by the addition of a modulating compound. A drug may be physically entrapped in the hydrogel, bound to the polymer forming the hydrogel structure, or bound to the first polypeptide or the polypeptide binding partner, and then be set free on addition of the modulating compound. Such a hydrogel comprising a drug may be injected into a patient, and drug release modulated by orally administering the modulating compound. | 06-23-2011 |
Martin Fussenegger, Maegenwil CH
| Patent application number | Description | Published |
|---|---|---|
| 20090247609 | SM-PROTEIN BASED SECRETION ENGINEERING - The present invention concerns the field of cell culture technology. It describes a novel method for enhancing the secretory transport of proteins in eukaryotic cells by heterologous expression of Munc18c, Sly1 or other members of the SM protein family. This method is particularly useful for the generation of optimized host cell systems with enhanced production capacity for the expression and manufacture of recombinant protein products. | 10-01-2009 |
| 20110124108 | EPIGENETIC ENGINEERING - The invention concerns the field of cell culture technology. It concerns production host cell lines with increased expression of ribosomal RNA (rRNA) achieved through reducing expression of NoCR proteins, especially of TIP-5. Those cell lines have improved secretion and growth characteristics in comparison to control cell lines. | 05-26-2011 |
